Mers breakthrough as University of Hong Kong researchers find combination of two drugs – cyclosporine and interferon – stops virus from spreading

Research showed that “a combination of two currently licensed agents was able to significantly inhibit virus replication and tissue damage by the MERS coronavirus in human bronchus and lung."

Multi-hospital outbreak of a Middle East respiratory syndrome coronavirus deletion variant, Jordan: A molecular, serologic, and epidemiologic investigation

A 2015 outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in Jordan involved a variant virus that acquired distinctive deletions in the accessory open reading frames.

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

Up to 50 percent of Middle East respiratory syndrome coronavirus (MERS-CoV) cases in Saudi Arabia have been classified as secondary, occurring from human-to-human transmission through contact with asymptomatic or symptomatic MERS-CoV infected individuals.

Epidemiological factors and worldwide pattern of Middle East respiratory syndrome coronavirus from 2013 to 2016

Researchers used the full details of MERS-CoV cases available on the disease outbreak news section of the World Health Organization website to extract demographic and clinical information, global distribution, contacts, and probable risk factors for the mortality of laboratory-confirmed MERS-CoV cases for analysis.